These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26119653)

  • 1. Predictors and Outcomes of Routine Versus Optimal Medical Therapy in Stable Coronary Heart Disease.
    Chun S; Qiu F; Austin PC; Ko DT; Mamdani M; Wijeysundera DN; Czarnecki A; Bennell MC; Wijeysundera HC
    Am J Cardiol; 2015 Sep; 116(5):671-7. PubMed ID: 26119653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents.
    Iijima R; Nakamura M; Matsuyama Y; Muramatsu T; Yokoi H; Hara H; Okada H; Ochiai M; Suwa S; Hozawa H; Kawai K; Awata M; Mukawa H; Fujita H; Nanto S;
    Am J Cardiol; 2016 Sep; 118(6):790-796. PubMed ID: 27544742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in Use of Optimal Medical Therapy in Patients With Nonobstructive Coronary Artery Disease: A Population-Based Study.
    Oxner A; Elbaz-Greener G; Qui F; Masih S; Zivkovic N; Alnasser S; Cheema AN; Wijeysundera HC
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
    Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
    J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice patterns and trends in the use of medical therapy in patients undergoing percutaneous coronary intervention in Ontario.
    Garg P; Wijeysundera HC; Yun L; Cantor WJ; Ko DT
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25122664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Long-Term Mortality in Patients With Previous Coronary Artery Bypass Grafting Who Underwent Percutaneous Coronary Intervention With Versus Without Optimal Medical Therapy.
    Nakamura Y; Asaumi Y; Miyagi T; Nakai M; Nishimura K; Sugane H; Matama H; Kataoka Y; Miyamoto Y; Takeishi Y; Noguchi T; Yasuda S
    Am J Cardiol; 2018 Jul; 122(2):206-212. PubMed ID: 29747859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study.
    Wijeysundera HC; Bennell MC; Qiu F; Ko DT; Tu JV; Wijeysundera DN; Austin PC
    J Gen Intern Med; 2014 Jul; 29(7):1031-9. PubMed ID: 24610309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction.
    Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
    Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Acharjee S; Teo KK; Jacobs AK; Hartigan PM; Barn K; Gosselin G; Tanguay JF; Maron DJ; Kostuk WJ; Chaitman BR; Mancini GB; Spertus JA; Dada MR; Bates ER; Booth DC; Weintraub WS; O'Rourke RA; Boden WE;
    Am Heart J; 2016 Mar; 173():108-17. PubMed ID: 26920603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China.
    He X; Wang Y; Cong H; Lu C; Wu J
    Clin Ther; 2019 Mar; 41(3):456-465.e2. PubMed ID: 30770126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
    Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries.
    Choo EH; Chang K; Lee KY; Lee D; Kim JG; Ahn Y; Kim YJ; Chae SC; Cho MC; Kim CJ; Kim HS; Jeong MH;
    J Am Heart Assoc; 2019 Jul; 8(14):e011990. PubMed ID: 31284804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
    Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
    Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy.
    Mäkikallio TH; Barthel P; Schneider R; Bauer A; Tapanainen JM; Tulppo MP; Perkiömäki JS; Schmidt G; Huikuri HV
    Am J Cardiol; 2006 Feb; 97(4):480-4. PubMed ID: 16461041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of asymptomatic carotid stenosis despite optimal medical therapy.
    Conrad MF; Boulom V; Mukhopadhyay S; Garg A; Patel VI; Cambria RP
    J Vasc Surg; 2013 Jul; 58(1):128-35.e1. PubMed ID: 23806255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.